Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Svendborg I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.1% 1.1% 0.9% 1.3% 1.6% 1.7% 6.1% 6.1%   Credit score (0-100)   87 86 88 79 73 72 39 39   Credit rating   A A A A A A BBB BBB   Credit limit (kDKK)   123.9 154.4 361.0 61.7 15.9 8.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,342 8,005 10,313 10,673 11,186 11,249 0.0 0.0   EBITDA   3,351 4,380 5,449 5,266 5,687 5,272 0.0 0.0   EBIT   3,199 3,934 4,998 4,815 5,234 4,799 0.0 0.0   Pre-tax profit (PTP)   3,013.4 3,828.7 4,900.2 4,736.8 5,178.6 4,681.1 0.0 0.0   Net earnings   3,013.4 3,828.7 4,900.2 4,736.8 5,178.6 4,681.1 0.0 0.0   Pre-tax profit without non-rec. items   3,013 3,829 4,900 4,737 5,179 4,681 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   2,248 2,068 1,830 1,592 1,467 1,205 0.0 0.0   Shareholders equity total   0.0 0.0 0.0 0.0 5,179 4,681 0.0 0.0   Interest-bearing liabilities   6,839 6,209 7,889 6,639 5,817 5,432 3,117 3,117   Balance sheet total (assets)   7,493 7,245 8,913 7,356 6,440 6,149 3,117 3,117   Net Debt   6,821 6,163 5,696 5,571 5,319 4,551 3,117 3,117     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,342 8,005 10,313 10,673 11,186 11,249 0.0 0.0   Gross profit growth   0.0% 26.2% 28.8% 3.5% 4.8% 0.6% -100.0% 0.0%   Employees   7 10 10 11 11 12 0 0   Employee growth %   0.0% 42.9% 0.0% 10.0% 0.0% 9.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,493 7,245 8,913 7,356 6,440 6,149 3,117 3,117   Balance sheet change%   0.0% -3.3% 23.0% -17.5% -12.5% -4.5% -49.3% 0.0%   Added value   3,350.9 4,379.6 5,449.2 5,266.1 5,685.1 5,272.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   6,275 -839 -902 -902 -790 -948 -1,205 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   50.4% 49.1% 48.5% 45.1% 46.8% 42.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   42.7% 53.4% 61.9% 59.2% 75.9% 76.3% 0.0% 0.0%   ROI %   46.8% 59.3% 69.9% 66.3% 84.1% 85.4% 0.0% 0.0%   ROE %   40.2% 52.0% 60.7% 58.2% 82.6% 95.0% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 0.0% 0.0% 44.6% 43.3% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   203.6% 140.7% 104.5% 105.8% 93.5% 86.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 112.3% 116.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.5% 1.7% 1.5% 1.1% 0.9% 2.2% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.1 0.1 0.4 0.3 0.2 0.3 0.0 0.0   Current Ratio   0.1 0.2 0.4 0.3 0.3 0.3 0.0 0.0   Cash and cash equivalent   18.5 46.0 2,193.0 1,068.4 497.7 881.5 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -6,427.4 -5,810.9 -5,584.0 -5,133.2 -4,795.8 -4,321.9 -1,558.3 -1,558.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   479 438 545 479 517 439 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   479 438 545 479 517 439 0 0   EBIT / employee   457 393 500 438 476 400 0 0   Net earnings / employee   430 383 490 431 471 390 0 0